1-8 of 8
Authors: J. Krop
Journal Article
012 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Page S224, https://doi.org/10.1016/j.jsxm.2020.04.248
Published: 01 July 2020
Journal Article
038 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Page S237, https://doi.org/10.1016/j.jsxm.2020.04.274
Published: 01 July 2020
Journal Article
011 Correlation Between Validated Instruments Used in the RECONNECT Studies Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Pages S223–S224, https://doi.org/10.1016/j.jsxm.2020.04.247
Published: 01 July 2020
Journal Article
020 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_1, January 2020, Pages S9–S10, https://doi.org/10.1016/j.jsxm.2019.11.023
Published: 01 January 2020
Journal Article
194 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_1, January 2020, Page S67, https://doi.org/10.1016/j.jsxm.2019.11.191
Published: 01 January 2020
Journal Article
193 Bremelanotide for Hypoactive Sexual Desire Disorder: Contraceptive Subgroups Efficacy Analysis Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_1, January 2020, Page S67, https://doi.org/10.1016/j.jsxm.2019.11.190
Published: 01 January 2020
Journal Article
029 Bremelanotide for Hypoactive Sexual Desire Disorders in the RECONNECT Studies: Analysis of Baseline Free Testosterone Level Quartile Subgroups Get access
The Journal of Sexual Medicine, Volume 16, Issue Supplement_3, June 2019, Pages S13–S14, https://doi.org/10.1016/j.jsxm.2019.03.486
Published: 01 June 2019
Journal Article
146 Conversations With Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of Hypoactive Sexual Desire Disorder Get access
The Journal of Sexual Medicine, Volume 16, Issue Supplement_1, April 2019, Page S75, https://doi.org/10.1016/j.jsxm.2019.01.154
Published: 01 April 2019
